SpectraCure has registered the trademark Q-PRO[®]
SpectraCure AB (publ) has obtained trademark protection for Q-PRO[®], the name of the new generation system, in Europe and in the USA. Applications to register the trademark have been submitted in Australia, China and Japan.[En bild som visar text, dator, bord
Automatiskt genererad beskrivning]
SpectraCure is developing a system for treatment of recurrent prostate cancer. The system is currently used in a clinical study in Canada, the United States, and the United Kingdom. The name of the system, Q-PRO[®], has now received trademark protection. The trademark protection means that the